TerminatedPHASE1, PHASE2NCT01065805

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Studying Neuroendocrine carcinoma of pancreas

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AHS Cancer Control Alberta
Principal Investigator
Michael B Sawyer, MD
Cross Cancer Institute
Intervention
18F-FLT(biological)
Enrollment
94 enrolled
Eligibility
16 years · All sexes
Timeline
2009 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01065805 on ClinicalTrials.gov

Other trials for Neuroendocrine carcinoma of pancreas

Additional recruiting or active studies for the same condition.

See all trials for Neuroendocrine carcinoma of pancreas →

← Back to all trials